INNOVARTE MEETS WITH SENATOR FELIPE KAST’S LEGISLATIVE TEAM
On March 24th, 2023, NGO INNOVARTE met with Senator Felipe Kast's legislative team to discuss the concerns and to discuss the organization's concerns and...
Pandemics Treaty: drafting groups begin
Innovarte shares the news N°5 about the negotiations of the Pandemics Treaty, the Member States start drafting groups, while civil society has little incidence...
Compulsory license for Trikafta, therapy for cystic fibrosis
September, 16
The Government of Uruguay has issued a public call for individuals interested in obtaining a license that allows for the importation, sale, and...
NATIONAL INSTITUTE OF HEALTH OF PERU AND WHO, IN COLLABORATION WITH...
On March 2nd, 2023, NGO INNOVARTE co-organized with the National Institute of Health of Peru and AIS Peru, the second workshop seminar on "WHO...
We met with Corfo’s Technological Capabilities Manager
Innovarte and KEI met with the Manager of Technological Capacities of CORFO, Fernando Hentzschel, and the advisor Claudia Saavedra. On this occasion, a collaboration...
Concern over Pandemic Agreement: Organizations send letters to LATAM ministries
Today, April 26, 2024, Innovarte ONG, together with other organizations working on access to health in Latin America: Acción Internacional por la Salud Perú;...
Compulsory license for the treatment of cystic fibrosis: an urgent step...
On September 2, various civil society organizations and patient groups submitted a request to the Executive Branch to declare the triple immunomodulatory therapy composed...
Innovarte collaborates in Conversatory of the Universidad Peruana Cayetano Heredia on...
On July 3, 2023, a seminar on the Pandemic Treaty currently under discussion at the WHO was held at the Universidad Peruana Cayetano Heredia,...
WHO Resolution on market transparency for medical devices: WHA 72.8
We invite you to read the following article on the importance of transparency in the costs of medicines and health products, which the WHO...
WE CONTINUE THE CAMPAIGN FOR PFIZER TO ALLOW THE DISTRIBUTION OF...
Paxlovid helps prevent #PERSISTENTCOVID and reduces hospitalization of older adults by 85%. But the pharmaceutical company does not allow the distribution of generics. Let...
